在心房动期间缺陷心脏瑞诺丁受体调节
John A Vest1, Xander H T Wehrens, Steven R Reiken
1Department of Physiology and Cellular Biophysics, Clyde and Helen Wu Center for Molecular Cardiology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.
Circulation
|April 27, 2005
概括
由于蛋白质激酶A (PKA) 过酸化,从心脏的诺丁受体2 (RyR2) 泄漏的 (Ca2+) 可能导致心房动 (AF). 这种RyR2功能障碍和减少calstabin2结合在狗和人类AF模型中都被观察到.
科学领域:
- 心血管研究研究心血管研究
- 分子心脏病学分子心脏病学
- 节律失常的机制 节律失常机制
背景情况:
- 从质网膜 (SR) 泄漏的 (Ca2+) 与心房动 (AF) 等心房律乱有关.
- 蛋白激酶A (PKA) 对心脏氨酸受体 (RyR2) 的过酸化可以导致SR Ca2+泄漏和心室失常,但其在AF中的作用尚不清楚.
研究的目的:
- 研究RyR2功能障碍在心房动 (AF) 中的作用.
- 研究RyR2的PKA酸化及其与AF中calstabin2结合的关联.
主要方法:
- 从AF和对照犬和人类收集了心房组织.
- 通过免疫沉和免疫阻塞,评估了RyR2和calstabin2结合的PKA酸化.
- 在平面脂质双层中测量RyR2通道电流.
主要成果:
- 来自AF狗和人类的心房组织显示,RyR2的PKA酸化增加,calstabin2结合减少.
- 来自AF狗的RyR2通道在透析期间呈现出增加的开放概率,这表明SR Ca2+泄漏的可能性.
- 这些发现表明AF中的RyR2通道功能障碍.
结论:
- 通过RyR2 PKA高酸化介导的SR Ca2+泄漏可能有助于AF的启动和维持.
- RyR2功能障碍是心房动的潜在机制.
相关概念视频
Mechanism of Cardiac Arrhythmias
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Regulation of Stroke Volume
The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Autoregulation of Blood Flow
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.


